Pharming Group to participate in April investor conferences

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Leiden, the Netherlands, March 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of April:

  • Van Lanschot Kempen Life Sciences Conference 2025, Amsterdam, NL, April 2-3, 2025
  • 24th Annual Needham Virtual Healthcare Conference, April 7-10, 2025
    Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present on Tuesday, April 8 at 10:15 am ET/16:15CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.

For more information about these conferences, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Van Lanschot Kempen or Needham representative.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Attachment

Staff

Recent Posts

Judge Orders Cancellation of Over 25 Million Adia Nutrition Shares, Bolstering Shareholder Value

Winter Park, Florida--(Newsfile Corp. - April 1, 2025) - Adia Nutrition (OTC Pink: ADIA), a…

17 minutes ago

Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Reported positive data from the Phase II MAvERIC-Pilot study investigating the impact of CardiolRx™ administered…

17 minutes ago

ECHO IQ SIGNS STRATEGIC PARTNERSHIP AND INTEGRATION AGREEMENTS WITH SCIMAGE AND MEDAXIOM TO EXPAND ECHOSOLV AS ACROSS 36 US CARDIOLOGY NETWORKS

EchoSolv AS will be fully integrated into ScImage's medical workflow platform, facilitating streamlined deployment within…

2 hours ago

Barco Announces Upcoming 2025 Sony Pictures Titles for Release in HDR: KARATE KID: LEGENDS, 28 YEARS LATER

LAS VEGAS, March 31, 2025 /PRNewswire/ --  On the first day of CinemaCon 2025, the annual…

2 hours ago

Cosmo Appoints Federico Sommariva as Chief Legal Counsel

Dublin, Ireland--(Newsfile Corp. - April 1, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43)…

6 hours ago

Teaching Doctors in the World’s Fastest-Growing Economy – Texila American University in Guyana

GEORGETOWN, Guyana, March 31, 2025 /PRNewswire/ -- As Guyana rockets to the top of the…

14 hours ago